IL1RL1 variant may affect the response to type 2 biologics in patients with severe asthma.
Nishi K, Matsumoto H, Sunadome H, Nagasaki T, Oguma T, Tashima N, Hayashi Y, Terada S, Morita K, Yoshimura C, Nishizaka Y, Sano A, Iwanaga T, Sano H, Haraguchi R, Tohda Y, Kawaguchi T, Matsuda F, Hirai T.
Nishi K, et al. Among authors: sano h.
ERJ Open Res. 2025 Jan 13;11(1):00448-2024. doi: 10.1183/23120541.00448-2024. eCollection 2025 Jan.
ERJ Open Res. 2025.
PMID: 39811553
Free PMC article.